Table of Contents September 01, 2017; Volume Issue Supplement 2

  1. Altmann, Annette

    1. Identification of Ligands and Translation to Clinical Applications
      Uwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John Babich
      Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791

  2. Babich, John

    1. Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers
      Klaus Kopka, Martina Benešová, Cyril Bařinka, Uwe Haberkorn and John Babich
      Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 17S-26S; DOI: https://doi.org/10.2967/jnumed.116.186775
    2. Identification of Ligands and Translation to Clinical Applications
      Uwe Haberkorn, Walter Mier, Klaus Kopka, Christel Herold-Mende, Annette Altmann and John Babich
      Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 27S-33S; DOI: https://doi.org/10.2967/jnumed.116.186791

  3. Barinka, Cyril

    1. Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers
      Klaus Kopka, Martina Benešová, Cyril Bařinka, Uwe Haberkorn and John Babich
      Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 17S-26S; DOI: https://doi.org/10.2967/jnumed.116.186775

  4. Benesova, Martina

    1. Glu-Ureido–Based Inhibitors of Prostate-Specific Membrane Antigen: Lessons Learned During the Development of a Novel Class of Low-Molecular-Weight Theranostic Radiotracers
      Klaus Kopka, Martina Benešová, Cyril Bařinka, Uwe Haberkorn and John Babich
      Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 17S-26S; DOI: https://doi.org/10.2967/jnumed.116.186775
    2. Therapeutic Radiometals Beyond 177Lu and 90Y: Production and Application of Promising α-Particle, β−-Particle, and Auger Electron Emitters
      Cristina Müller, Nicholas P. van der Meulen, Martina Benešová and Roger Schibli
      Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 91S-96S; DOI: https://doi.org/10.2967/jnumed.116.186825

  5. Boas, F. Edward

    1. Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes
      F. Edward Boas, Lisa Bodei and Constantinos T. Sofocleous
      Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 104S-111S; DOI: https://doi.org/10.2967/jnumed.116.187229

  6. Bodei, Lisa

    1. In Memoriam: Dirk J. Kwekkeboom (1958–2017)
      Lisa Bodei
      Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 7A;
    2. Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes
      F. Edward Boas, Lisa Bodei and Constantinos T. Sofocleous
      Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 104S-111S; DOI: https://doi.org/10.2967/jnumed.116.187229
    3. Somatostatin Receptor 2–Targeting Compounds
      Daan A. Smit Duijzentkunst, Dik J. Kwekkeboom and Lisa Bodei
      Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 54S-60S; DOI: https://doi.org/10.2967/jnumed.117.191015

  7. Brouwers, Adrienne H.

    1. Theranostics Using Antibodies and Antibody-Related Therapeutics
      Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries
      Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940

  8. Calais, Jeremie

    1. Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
      Matthias Eiber, Wolfgang P. Fendler, Steven P. Rowe, Jeremie Calais, Michael S. Hofman, Tobias Maurer, Sarah M. Schwarzenboeck, Clemens Kratowchil, Ken Herrmann and Frederik L. Giesel
      Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 67S-76S; DOI: https://doi.org/10.2967/jnumed.116.186767

  9. Cremonesi, Marta

    1. Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?
      Uta Eberlein, Marta Cremonesi and Michael Lassmann
      Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 97S-103S; DOI: https://doi.org/10.2967/jnumed.116.186841

  10. De Groot, Derk Jan A.

    1. Theranostics Using Antibodies and Antibody-Related Therapeutics
      Kirsten L. Moek, Danique Giesen, Iris C. Kok, Derk Jan A. de Groot, Mathilde Jalving, Rudolf S.N. Fehrmann, Marjolijn N. Lub-de Hooge, Adrienne H. Brouwers and Elisabeth G.E. de Vries
      Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 83S-90S; DOI: https://doi.org/10.2967/jnumed.116.186940
« Previous (Pages : 1 2 3 4 5 6 ... 6) Next »
Back to top

In this issue